[1] 李莉莉,钟佩茹.非创伤性股骨头坏死发病相关因素及信号通路机制的研究进展[J].医学综述,2018,24(1):22-27.[2] 蔡伟斌,范积平,吕扬阳,等. 髓芯减压术、自体髂骨移植术与骨髓间充质干细胞移植术联合治疗战创伤致早期成人股骨头坏死[J]. 广东医学,2016,37(1):106-108.[3] Ehlinger M, Moser T, Adam P, et al. Early prediction of femoral head avascular necrosis following neck fracture.Orthop Traumatol Surg Res. 2011;97(1):79-88.[4] Bastian JD, Turina M, Siebenrock KA, et al. Long-term outcome after traumatic anterior dislocation of the hip.Arch Orthop Trauma Surg. 2011;131(9):1273-1278.[5] Song HJ, Lan BS, Cheng B, et al. Treatment of early avascular necrosis of femoral head by small intestinal submucosal matrix with peripheral blood stem cells. Transplant Proc. 2011;43(5):2027-2032.[6] Vaishya R, Agarwal AK, Gupta N, et al. Sartorius muscle pedicle iliac bone graft for the treatment of avascular necrosis of femur head.J Hip Preserv Surg. 2016;3(3):215-222.[7] Xiao D, Ye M, Li X, et al. Biomechanics analysis for the treatment of ischemic necrosis of the femoral head by using an interior supporting system.Int J ClinExp Med. 2015;8(3): 4551-4556.[8] Yuan HF, Zhang J, Guo CA, et al. Clinical outcomes of osteonecrosis of the femoral head after autologous bone marrow stem cell implantation: a meta-analysis of seven case-control studies.Clinics (Sao Paulo). 2016;71(2):110-113.[9] 张洪雨,马志强,刘建宇.干细胞治疗股骨头坏死的相关研究[J].东南大学学报:医学版, 2015,34(2):291-294.[10] Fu Q, Tang NN, Zhang Q, et al. Preclinical Study of Cell Therapy for Osteonecrosis of the Femoral Head with Allogenic Peripheral Blood-Derived Mesenchymal Stem Cells.Yonsei Med J. 2016;57(4):1006-1015.[11] Hernigou P, Flouzat-Lachaniette CH,Delambre J, et al. Osteonecrosis repair with bone marrow cell therapies: state of the clinical art.Bone. 2015;70:102-109.[12] 樊天,余方圆, 温振涛,等. 非创伤性股骨头坏死的机制及早期治疗的研究进展[J]. 现代生物医学进展, 2016, 16(21):4170-4173.[13] 王天胜,滕寿发,张英霞,等. 骨髓基质干细胞移植在激素性股骨头坏死治疗中的作用机制研究[J]. 临床和实验医学杂志, 2015, 14(1):10-12.[14] Wang T, Teng S, Zhang Y, et al. Role of mesenchymal stem cells on differentiation in steroid-induced avascular necrosis of the femoral head.ExpTher Med. 2017;13(2):669-675.[15] Tian L, Wen Q, Dang X, et al. Immune response associated with Toll-like receptor 4 signaling pathway leads to steroid-induced femoral head osteonecrosis.BMC Musculoskelet Disord. 2014;15:18.[16] 满达,赵建民,刘瑞,等. 股骨头坏死非手术治疗的研究进展[J]. 中国当代医药, 2017, 24(2):13-15.[17] Tripathy SK, Goyal T, Sen RK.Management of femoral head osteonecrosis: Current concepts.Indian J Orthop. 2015;49(1): 28-45.[18] 石正松,李强,宁寅宽,等. hBMP-2基因转染兔骨髓间充质干细胞体内移植后hBMP-2的活性检测[J]. 中国骨质疏松杂志, 2015, 21(11):1333-1337.[19] García-Gareta E, Hua J, Blunn GW.Osseointegration of acellular and cellularizedosteoconductive scaffolds: is tissue engineering using mesenchymal stem cells necessary for implant fixation?J Biomed Mater Res A. 2015;103(3): 1067-1076.[20] Wyles CC, Houdek MT, Crespo-Diaz RJ, et al. Adipose-derived Mesenchymal Stem Cells Are Phenotypically Superior for Regeneration in the Setting of Osteonecrosis of the Femoral Head.Clin Orthop Relat Res. 2015;473(10): 3080-3090.[21] Chen C, Qu Z, Yin X, et al. Efficacy of umbilical cord-derived mesenchymal stem cell-based therapy for osteonecrosis of the femoral head: A three-year follow-up study.Mol Med Rep. 2016;14(5):4209-4215.[22] Veronesi F, Torricelli P, Della Bella E, et al. In vitro mutual interaction between tenocytes and adipose-derived mesenchymal stromal cells.Cytotherapy. 2015;17(2):215-223.[23] Ferrara N, Henzel WJ.Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells.BiochemBiophys Res Commun. 1989;161(2):851-858.[24] Veronesi F, Torricelli P, Della Bella E, et al. In vitro mutual interaction between tenocytes and adipose-derived mesenchymal stromal cells.Cytotherapy. 2015;17(2):215-223.[25] Daltro GC, Fortuna V, de Souza ES, et al. Efficacy of autologous stem cell-based therapy for osteonecrosis of the femoral head in sickle cell disease: a five-year follow-up study.Stem Cell Res Ther. 2015;6:110.[26] 王伟,刘丹平,张德志,等. 自体骨髓间充质干细胞骨泥治疗早期股骨头缺血性坏死近期疗效分析[J]. 医学与哲学, 2016, 37(8): 47-50.[27] Ma XW, Cui DP, Zhao DW.Vascular endothelial growth factor/bone morphogenetic protein-2 bone marrow combined modification of the mesenchymal stem cells to repair the avascular necrosis of the femoral head.Int J Clin Exp Med. 2015;8(9):15528-15534.[28] Liu X, Li Q, Niu X, et al. Exosomes Secreted from Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Prevent Osteonecrosis of the Femoral Head by Promoting Angiogenesis.Int J Biol Sci. 2017;13(2):232-244.[29] Hernigou P, Trousselier M, Roubineau F, et al. Stem Cell Therapy for the Treatment of Hip Osteonecrosis: A 30-Year Review of Progress.Clin Orthop Surg. 2016;8(1):1-8.[30] 李民,李书奎,陈汉文,等. 髓芯减压后自体MCS移植治疗早期股骨头坏死效果[J]. 齐鲁医学杂志, 2016,31(3):340-341.[31] 王冠. 骨髓间充质干细胞治疗股骨头坏死的临床分析[J]. 中国卫生标准管理, 2016, 7(3):32-33.[32] Piuzzi NS, Chahla J, Jiandong H, et al. Analysis of Cell Therapies Used in Clinical Trials for the Treatment of Osteonecrosis of the Femoral Head: A Systematic Review of the Literature.J Arthroplasty. 2017;32(8):2612-2618.[33] Papakostidis C, Tosounidis TH, Jones E, et al. The role of "cell therapy" in osteonecrosis of the femoral head.A systematic review of the literature and meta-analysis of 7 studies. Acta Orthop. 2016;87(1):72-78.[34] 孙明林,徐辉,王景贵. 重组人骨形态发生蛋白2/纤维蛋白胶植入联合髓芯减压治疗兔股骨头缺血性坏死[J].中国组织工程研究与临床康复,2009,13(12):2257-2260.[35] 薛元锁,时述山,李亚非,等.激素性股骨头坏死病程中骨形态发生蛋白-2的改变及其意义[J].中华实验外科杂志, 2000,17(5): 455-456.[36] Hernigou P, Flouzat-Lachaniette CH, Delambre J, et al. Osteonecrosis repair with bone marrow cell therapies: state of the clinical art.Bone. 2015;70:102-109.[37] Villa JC, Husain S, van der List JP, et al. Treatment of Pre-Collapse Stages of Osteonecrosis of the Femoral Head: a Systematic Review of Randomized Control Trials.HSS J. 2016;12(3):261-271.[38] Banno K, Yoder MC.Tissue regeneration using endothelial colony-forming cells: promising cells for vascular repair. Pediatr Res. 2018;83(1-2):283-290.[39] Corre I, Paris F, Huot J.The p38 pathway, a major pleiotropic cascade that transduces stress and metastatic signals in endothelial cells.Oncotarget. 2017;8(33):55684-55714.[40] Liao S, Luo C, Cao B, et al. Endothelial Progenitor Cells for Ischemic Stroke: Update on Basic Research and Application.Stem Cells Int. 2017;2017:2193432. [41] Tenreiro MM, Correia ML, Brito MA.Endothelial progenitor cells in multiple myeloma neovascularization: a brick to the wall.Angiogenesis. 2017;20(4):443-462.[42] Samee M, Kasugai S, Kondo H, et al. Bone morphogenetic protein-2 (BMP-2) and vascular endothelial growth factor (VEGF) transfection to human periosteal cells enhances osteoblast differentiation and bone formation.J Pharmacol Sci. 2008;108(1):18-31.[43] Bianconi V, Sahebkar A, Kovanen P, et al. Endothelial and cardiac progenitor cells for cardiovascular repair: A controversial paradigm in cell therapy.PharmacolTher. 2018; 181:156-168.[44] Schlegel F, Appler M, Halling M, et al. Reprogramming Bone Marrow Stem Cells to Functional Endothelial Cells in a Mini Pig Animal Model.Med SciMonit Basic Res. 2017;23:285-294.[45] Carmona MD, Cañadillas S, Romero M, et al. Intramyocardial bone marrow mononuclear cells versus bone marrow-derived and adipose mesenchymal cells in a rat model of dilated cardiomyopathy.Cytotherapy. 2017;19(8):947-961.[46] Fukunishi T, Best CA, Ong CS, et al. Role of Bone Marrow Mononuclear Cell Seeding for Nanofiber Vascular Grafts. Tissue Eng Part A. 2018;24(1-2):135-144. |